Management of anxiety and depression in patients with COPD

References

• Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet370, 765–773 (2007).
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Rabe K. Burden and clinical features of chronic obstructive pulmonary disease. Lancet364, 613–620 (2004).
   PubMed Web of Science ®Google Scholar
• Muray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet349, 1498–1504 (1997).
   Google Scholar
• Jemal A, Ward E, Hao Y, Thun M. Trends in the leading cause of death in the United States, 1970–2002. JAMA294, 1255–1259 (2005).
   PubMed Web of Science ®Google Scholar
• Mannino DM, Homa DM, Akinbami IJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance – United States, 1971–2000. Respir. Care47, 1184–1199 (2002).
   PubMedGoogle Scholar
• Friedman M, Hilleman DE. Economic burden of chronic obstructive pulmonary disease. Impact of new treatment options. Pharmacoeconomics19, 245–254 (2001).
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Baldwin RC, Connolly MJ. Mood disorders in elderly patients with chronic obstructive pulmonary disease. Rev. Clin. Gerontol.10, 191–202 (2000).
   Google Scholar
• National Collaborating Centre for Chronic Conditions. Chronic obstructive pulmonary disease: national clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax59(Suppl. 1), 1–232 (2004).
   Google Scholar
• Nici L, Donner C, Wouters E et al. Amercian Thoracic Society/ European Respiratory Statement on pulmonary rehabilitation. Am. J. Respir. Crit. Care Med.173, 1390–1413 (2006).
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Baldwin RC, Connolly MJ. Yohannes AM, Connolly MJ, Baldwin RC. A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease. Int. J. Geriatr. Psychiatry16, 451–454 (2001).
   PubMed Web of Science ®Google Scholar
• Sirey JA, Raue PJ, Alexopoulos GS. An intervention to improve depression care in older adults with COPD. Int. J. Geriatr. Psychiatry22, 154–159 (2007).
   PubMed Web of Science ®Google Scholar
• Bosley CM, Corden ZM, Rees PJ, Cochrane GM. Psychological factors associated with use of home nebulized therapy for COPD. Eur. Respir. J.9, 2346–2350 (1996).
   PubMed Web of Science ®Google Scholar
• Garrod R, Marshall J, Barley E, Jones PW. Predictors of success and failure in pulmonary rehabilitation. Eur. Respir. J.27, 788–794 (2006).
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly out-patients with chronic obstructive pulmonary disease: prevalence and validation of BASDEC screening questionnaire. Int. J. Geriatr. Psychiatry15, 1090–1096 (2000).
   PubMed Web of Science ®Google Scholar
• Coultas DB, Edwards DW, Barnett B, Wludyka P. Predictors of depressive symptoms in patients with COPD and health impact. COPD4, 23–28 (2007).
   PubMedGoogle Scholar
• McCathie HCF, Spence SH, Tate RL. Adjustment to chronic obstructive pulmonary disease: the importance of psychological factors. Eur. Respir. J.19, 47–53 (2002).
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Baldwin RC, Connolly MJ. Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. Age Ageing34, 491–496 (2005).
   PubMed Web of Science ®Google Scholar
• Kim HF, Kunik ME, Mollinari VA et al. Functional impairment in COPD patients the impact of anxiety and depression. Psychosomatics41, 465–471 (2000).
   PubMed Web of Science ®Google Scholar
• Borson S, McDonald GJ, Gayle T, Deffebach M, Lakshminarayan S, VanTunien C. Improvement in mood, physical symptoms and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics33, 190–201 (1992).
   PubMed Web of Science ®Google Scholar
• Eiser NM, Evans S, Jeffers A, Quirk F. Effects of psychotherapy on dyspnoea in moderately severe: a pilot study. Eur. Respir. J.10, 1581–1584 (1997).
   PubMed Web of Science ®Google Scholar
• de Godoy DV, de Godoy RF. A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Arch. Phys. Med. Rehabil.84, 1154–1157 (2003).
   PubMed Web of Science ®Google Scholar
• Emery CF, Schein RL, Hauck ER, MacIntyre NR. Psychological and cognitive outcome of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. Health Psychology17, 232–240 (1998).
   PubMed Web of Science ®Google Scholar
• McDougall FA, Kvaal K, Matthews FE et al. Prevalence of depression in older people in England and Wales: the MRC CFA study. Psychol. Med.37, 1787–1795 (2007).
   PubMed Web of Science ®Google Scholar
• Hackett ML, Yapa C, Parag V, Anderson CS. Frequency of depression after stroke: a systematic review of observational studies. Stroke36, 1330–1340 (2005).
   PubMed Web of Science ®Google Scholar
• Friedman E, Thomas SA, Liu F, Morton PG, Chapa D, Gottlieb SS. Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality. Am. Heart J.152, 940.e1–940.e8 (2006).
   PubMed Web of Science ®Google Scholar
• Cummings JL, Masterman DL. Depression in patients with Parkinson’s disease. Int. J. Geriatr. Psychiatry14, 711–718 (1999).
   PubMed Web of Science ®Google Scholar
• Koenig HG. Differences between depressed patients with heart failure and those with pulmonary disease. Am. J. Geriatr. Psychiatry14, 211–219 (2006).
   PubMed Web of Science ®Google Scholar
• der Kooy KV, Hout HV, Marwijk H, Marten H, Stehouwer C, Beekman A. Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int. J. Geriatr. Psychiatry22, 613–626 (2007).
   Google Scholar
• Frauser-Smith N, Lesperance F. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch. Gen. Psychiatry65, 62–71 (2008).
   Google Scholar
• Sin DD, Man SFP. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc. Am. Thorac. Soc.2, 8–11 (2005).
   PubMedGoogle Scholar
• Sin DD, Man SFP. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation107, 1514–1519 (2003).
   PubMed Web of Science ®Google Scholar
• Karagi B, Rifkin A, Doddi S, Koli R. The prevalence of anxiety disorders in patients with chronic obstructive pulmonary disease. Am. J. Psychiatry147, 200–201 (1990).
   Google Scholar
• Yellows P, Alpers J, Bowden J, Byrant G, Ruffin R. Psychiatric morbidity in patients with chronic airflow obstruction. Med. J. Aust.146, 305–307 (1987).
   Google Scholar
• Rose C, Wallace L, Dickson R et al. The most effective psychologically-based treatments to reduce anxiety and panic in patients with chronic obstructive pulmonary disease (COPD): a systematic review. Patient Educ. Couns.47, 311–318 (2002).
   PubMed Web of Science ®Google Scholar
• Fan VS, Ramsey SD, Giadino ND et al. Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch. Intern. Med.67, 2345–2353 (2007).
   Google Scholar
• Ng TP, Niti M, Tan W-C, Cao Z, Ong K-C, Eng P. Depressive symptoms and chronic obstructive pulmonary disease. Effect on mortality, hospital readmission, symptom burden, functional status and quality of life. Arch. Intern. Med.167, 60–67 (2007).
   PubMed Web of Science ®Google Scholar
• van Mannen JG, Bindels PJE, Dekker FW, Jzermans CJI, van der Zee JS, Schade E. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax57, 412–416 (2002).
   Google Scholar
• Laurin C, Lavoie KL, Bacon SL et al. Sex differences in the prevalence of psychiatric disorders and psychological disorders in patients with COPD. Chest132, 148–155 (2007).
   PubMed Web of Science ®Google Scholar
• Jeste ND, Hays JC, Steffens DC. Clinical correlates of anxious depression among elderly patients with depression. J. Affect. Disord.90, 37–41 (2006).
   Google Scholar
• Fava M, Alpert JE, Carmin CN et al. Clinical correlates and symptom patterns of anxious depression among patiens with major depression in STAR*D. Psychol. Med.34, 1299–1308 (2004).
   PubMed Web of Science ®Google Scholar
• Sherbourne CD, Wells KB. Course of depression in patients with comorbid anxiety disorders. J. Affect. Disord.43, 245–250 (1997).
   PubMedGoogle Scholar
• Tyrer P. The case for cothymia: mixed anxiety and depression as a single diagnosis. Br. J. Psychiatry179, 191–193 (2001).
   PubMed Web of Science ®Google Scholar
• Chavannes NH, Hujbers MJH, Schermer TRJ et al. Associations of depressive symptoms with gender, body mass index and dyspnoea in primary care COPD patients. Fam. Pract.22, 604–607 (2005).
   PubMed Web of Science ®Google Scholar
• Crockett AJ, Cranston JM, Moss JR, Alpers JH. The impact of anxiety, depression and living alone in chronic obstructive pulmonary disease. Qual. Life Res.11, 309–316 (2002).
   Google Scholar
• Yohannes AM, Baldwin RC, Connolly MJ. Prevalence of sub-threshold depression in elderly patients with chronic obstructive pulmonary disease. Int. J. Geriatr. Psychiatry18, 412–416 (2003).
   PubMed Web of Science ®Google Scholar
• Koenig HG, Vandermeer J, Chambers CSA, Burr-Crutchfield L, Johnson J. Comparison of major depression and minor depression in older medical inpatients with chronic heart and pulmonary disease. Psychosomatics47, 1–8 (2006).
   Google Scholar
• Copeland JRM, Kelleher MJ, Kellett JM et al. A semi-structured clinical interview for the assessment of diagnosis and mental test in the elderly: the Geriatric Mental State Schedule. Psychol. Med.6, 439–449 (1976).
   PubMed Web of Science ®Google Scholar
• Unutzer J. Late-life depression. N. Engl. J. Med.357, 2269–2276 (2007).
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association (APA). Diagnostic and Statistical Manual Version IV. APA, Washington, DC, USA (1994).
   Google Scholar
• Eiser N, Harte R, Spiros K, Phillips C, Isaac MT. Effect of treating depression on quality of life and exercise tolerance in severe COPD. COPD2, 233–241 (2005).
   PubMedGoogle Scholar
• Silverworth EJ, Doraiswamy PM, Clary GL et al. Citalopram and quality of life in lung transplant recipients. Psychosomatics45, 271–272 (2004).
   Google Scholar
• Griffiths TL, Burr ML, Campbell IA et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomized controlled trial. Lancet355, 362–368 (2000).
   PubMed Web of Science ®Google Scholar
• Withers NJ, Rudkin ST, White RJ. Anxiety and depression in severe chronic obstructive pulmonary disease: the effects of pulmonary rehabilitation. J. Cardiopulm. Rehabil.19, 362–365 (1999).
   PubMedGoogle Scholar
• Guell R, Resqueti V, Sangenis M et al. Impact of pulmonary rehabilitation on psychosocial morbidity in patients with severe COPD. Chest129, 899–904 (2006).
   PubMed Web of Science ®Google Scholar
• Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann. Intern. Med.122, 823–832 (1995).
   PubMed Web of Science ®Google Scholar
• White RJ, Rudkin ST, Harrison ST, Day KL, Harvey IM. Pulmonary rehabilitation compared with brief advice given for chronic obstructive pulmonary disease. J. Cardiopulm. Rehabil.22, 338–344 (2002).
   Google Scholar
• Scherer Y, Schmieder LE, Shimmel S. The effects of education alone and in combination with pulmonary rehabilitation on self-efficacy in patients with COPD. Rehabil. Nurs.23, 71–77 (1998).
   PubMedGoogle Scholar
• McCathie HCF, Spence SH, Tate RL. Adjustment to chronic obstructive pulmonary disease: the importance of psychological factors. Eur. Respir. J.19, 47–53 (2002).
   PubMed Web of Science ®Google Scholar
• Garuti G, Cilione C, Dell’Orso D et al. Impact of comprehensive pulmonary rehabilitation on anxiety and depression in hospitalized COPD patients. Monaldi Arch. Chest Dis.59, 56–61 (2003).
   PubMedGoogle Scholar
• Alexopoulos GS, Sirey JA, Raue PJ, Kanellopoulos D, Clark TE, Novitch RS. Outcomes of depressed patients undergoing inpatient pulmonary rehabilitation. Am. J. Geriatr. Psychiatry14, 466–475 (2006).
   PubMed Web of Science ®Google Scholar
• Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression. Guildford Press, NY, USA (1979).
   Google Scholar
• Kunik ME, Veazey C, Cully JA et al. COPD education and cognitive behavioural therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial. Psychol. Med.37, 1–12 (2007).
   Google Scholar
• Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE; Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann. Intern. Med.142, 233–239 (2005).
   PubMed Web of Science ®Google Scholar
• Tashkin DP, Kanner R, Bailey W et al. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomized trial. Lancet357, 1571–1575 (2001).
   PubMed Web of Science ®Google Scholar
• Wagena EJ, Knipschild PG, Hubers MJH, Wouters EFM, van Schayck CP. Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. Arch. Intern. Med.165, 2286–2292 (2005).
   PubMed Web of Science ®Google Scholar
• Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database of Syst. Rev.1, CD000031 (2007).
   PubMed Web of Science ®Google Scholar
• Jorenby DE, Hays JT, Rigotti NA et al. for the varenicline Phase 3 Study Group. Efficacy of Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist vs placebo or sustained-release bupropion for smoking cessation. A randomized controlled trial. JAMA296, 56–63 (2006).
   PubMed Web of Science ®Google Scholar
• DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for non-compliance with medical treatment: meta-analysis of the effect of anxiety and depression on patient adherence. Arch. Intern. Med.160, 2101–2107 (2000).
   PubMed Web of Science ®Google Scholar
• Almagro P, Calbo E, de Echagiien AO et al. Mortality after hospitalization for COPD. Chest121, 1441–1448 (2002).
   PubMed Web of Science ®Google Scholar
• Adams SG, Smith PK, Allan PF, Anzueto A, Pugh PA, Cornell JE. Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Arch. Intern. Med.167, 551–561 (2007).
   PubMed Web of Science ®Google Scholar
• Chew-Graham CA, Lovell K, Roberts C et al. A randomized controlled trial to test the feasibility of a collaborative care model for the management of depression in older people. Br. J. Gen. Pract.57, 364–370 (2007).
   PubMed Web of Science ®Google Scholar
• Unutzer J, Katon W, Callahan CM et al. Collaborative care management of late-life depression in the primary setting. A randomized controlled trial. JAMA288, 2836–2845 (2002).
   PubMed Web of Science ®Google Scholar
• Wong SYS, Lee K, Chan K, Lee A. What are the barriers faced by general practitioners in treating depression and anxiety in Hong Kong? Int. J. Clin. Pract.60, 437–441 (2006).
   Google Scholar
• Richards JC, Ryan P, McCabe MP, Groom G, Hickie IB. Barriers to the effective management of depression in general practice. Aust. NZ J. Psychiatry38, 795–803 (2004).
   PubMed Web of Science ®Google Scholar
• Alexopoulos GS, Raue PJ, Sirey JA, Arean P. Developing an intervention for depressed, chronically medically ill elders: a model from COPD. Int. J. Geriatr. Psychiatry23(5), 447–453 (2007).
   Google Scholar
• Kunik ME, Roundy K, Veazy C et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest127, 1205–1211 (2005).
   PubMed Web of Science ®Google Scholar
• Dowson CA, Town GI, Frampton C, Mulder RT. Psychopathology and illness beliefs influence COPD self-management. J. Psychosom. Res.56, 333–340 (2004).
   PubMed Web of Science ®Google Scholar
• Brenes GA. Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom. Med.65, 963–970 (2003).
   PubMed Web of Science ®Google Scholar
• Yesavage JA, Brink TL, Rose TL et al. Development and validation of a geriatric depression screening scale: a preliminary report. J. Psychiatr. Res.17, 37–49 (1982).
   PubMed Web of Science ®Google Scholar
• Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl. Psycholog. Measure.1, 385–401 (1977).
   Web of Science ®Google Scholar
• Montgomery SA, Asberg S. A new depression scale designed to be sensitive to change. Br. J. Psychiatry134, 382–389 (1979).
   PubMed Web of Science ®Google Scholar
• Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol.6, 278–286 (1967).
   PubMed Web of Science ®Google Scholar
• Copeland JRM, Dewey ME, Griffiths-Jones HM. A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychol. Med.16, 86–99 (1986).
   Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr. Scand.67, 361–370 (1983).
   PubMed Web of Science ®Google Scholar